Showing results (491-500 of 5,191) with videos related to
Sort By:
Pageof 520
Journal of Immunological Methods|June 27, 2012
Enzyme-linked immunosorbent assay (ELISA) and blocking with bovine serum albumin (BSA)--not all BSAs are alikeYuhong Xiao, Stuart N IsaacsThe Oncologist|April 7, 2023
Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate CancerSamuel R Denmeade, Laura A Sena, Hao Wang, et al.Journal of Medicinal Chemistry|May 23, 2013
Structural optimization, biological evaluation, and application of peptidomimetic prostate specific antigen inhibitorsMaya B Kostova, D Marc Rosen, Ying Chen, et al.The Journal of Urology|June 7, 2000
Complete androgen blockade for prostate cancer: what went wrong?M Laufer, S R Denmeade, V J Sinibaldi, et al.Oncotarget|June 2, 2018
PSA-selective activation of cytotoxic human serine proteases within the tumor microenvironment as a therapeutic strategy to target prostate cancerOliver C Rogers, Lizamma Anthony, D Marc Rosen, et al.The Prostate|February 3, 2016
Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategyEmmanuel S Akinboye, W Nathaniel Brennen, D Marc Rosen, et al.The Prostate|May 7, 2019
Risk of development of visceral metastases subsequent to abiraterone vs placebo: An analysis of mode of radiographic progression in COU-AA-302Benjamin A Teply, Fang Qiu, Emmanuel S Antonarakis, et al.Journal of Clinical Psychology|May 14, 2024
Narcissistic personality disorder in the ICD-11: Severity and trait profiles of grandiosity and vulnerabilityNicholas J S Day, Ava Green, Georgia Denmeade, et al.The Prostate|January 1, 1992
Effect of pentosan, a novel cancer chemotherapeutic agent, on prostate cancer cell growth and motilityK J Pienta, B C Murphy, W B Isaacs, et al.Pageof 520